我们是谁

The 创新临床和结果研究 (iCOR) team is a hub of cutting-edge clinical re搜索 at the 托马斯J. 龙药学院. iCOR provides opportunities for students to collaborate with peers, 教师, fellows and industry pharmacists on high-impact re搜索 projects. The team is led by accomplished 教师 members who are leading experts in their fields and is supported by an impressive network of successful alumni who are now leaders in industry.

我们所做的

As trailblazers in the medical device and dietary supplement space, the iCOR team spearheads innovative re搜索 projects and clinical trials to deliver consequential findings that impact patient care 和 scientific community. We engage in innovative projects which use existing data or data collected by recruiting more than 100 volunteers. We focus on studies which can be conducted rapidly, between six months and two years. Completed projects have ranged from proof-of-concepts to studies validating causality. iCOR conducts re搜索 in collaboration with the Fellowship in Industry Program, 其中包括与 流治疗, 基因泰克 和 美国空军.

我们要去的地方

以广泛的研究和以前的工作为基础, iCOR continues to pioneer innovative re搜索 through a robust pipeline of ongoing re搜索 programs, including re搜索 on continuous glucose monitoring devices and enhanced external counter pulsation treatments. Through continuous evaluation of the current industry landscape, iCOR的研究重点保持领先地位. 除了, the team seeks to continue to strategically develop working relationships with leading pharmaceutical and biotechnology companies.

We strive to advance patient care through innovative re搜索. Our goal is to train students and prepare them to become leaders in the pharmaceutical industry by providing rich learning experiences, 领导机会和指导.

What started as a passion project for one student to pursue the pharmaceutical industry pathway has grown into a track for students to excel in this arena. 随着iCOR多年来的发展, the scope of the projects conducted by its members have also expanded. 我们学生的工作, 教师 and alumni has been nationally recognized through numerous publications and presentations. Our projects illustrate the classic interplay between science and scientists, a cat-and-mouse game in the pursuit of optimizing human health.

2022届毕业生


2021届毕业生

  • 安阮, PharmD - Clinical 研究 and Drug Development Fellow at UNC
  • 伊丽莎白·林德曼他是Regeneron公司生物制剂副总裁
  • 凯瑟琳许，制药博士-美国市场 & Global Commercial Strategy, Rare Diseases at Sanofi Genzyme
  • Simran Randhawa全球医学事务:炎症 & 辉瑞公司免疫学研究员
驾车范教授肖像

"iCOR is filled with opportunities to explore a career within the pharmaceutical industry. Having the opportunity to learn about the drug development process, conducting clinical trials and analyzing clinical data challenged my critical and clinical knowledge throughout my experience within iCOR. It helped to cement my passion for re搜索 and my continued desire to to make an impact in health care."

— 驾车范教授 ' 22，药学博士/博士候选人
正规博彩十大网站

"iCOR had a profound impact on my journey through pharmacy school. The collaborative relationship between 教师 and students of iCOR creates an environment that combines critical thinking and science, 并最终最大化患者的治疗效果. 我得到了进行文献综述的机会, 设计和执行临床试验, 并在手稿中总结得出的数据. It helped me realize my passion for pursuing a career in clinical development within the pharmaceutical industry."

— 瑞奇·菲利波斯，22年, PharmD
辉瑞公司临床开发研究员

瑞奇Philipossian - iCOR药房校友
iCOR项目流水线图

“iCOR gave me the opportunity to continually challenge my critical thinking and broaden my perspective. My understanding of drug development deepened through hands-on experience with designing and executing the first virtual clinical trial at Pacific. I witnessed firsthand how vital re搜索 is in impacting and improving patient care. The skills and lessons I learned from the supportive mentorship and unique experiences in iCOR will stay with me throughout my career.”

— 吉米Dovan, 22岁, PharmD
Regulatory Affairs: Advertising and Promotion Fellow at Merck

正规博彩十大网站

iCOR@302252.com